A Prospective, Molecular Epidemiology Study of EGFR Mutations in Asian Patients with Advanced Non–Small-Cell Lung Cancer of Adenocarcinoma Histology (PIONEER)-Reference-Cited by-同舟云学术

A Prospective, Molecular Epidemiology Study of EGFR Mutations in Asian Patients with Advanced Non–Small-Cell Lung Cancer of Adenocarcinoma Histology (PIONEER)

Published:2014-02 Issue:2 Volume:9 Page:154-162
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Shi Yuankai,Au Joseph Siu-Kie,Thongprasert Sumitra,Srinivasan Sankar,Tsai Chun-Ming,Khoa Mai Trong,Heeroma Karin,Itoh Yohji,Cornelio Gerardo,Yang Pan-Chyr

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference34 articles.

1. Guidelines Working Group. . Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;D'Addario;Ann Oncol,2010

2. Guidelines Working Group. . Early stage and locally advanced (non-metastatic) non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Crinò;Ann Oncol,2010

3. Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma;Mok;N Engl J Med,2009

4. First-SIGNAL: first-line single-agent iressa versus gemcitabine and cisplatin trial in never-smokers with adenocarcinoma of the lung;Han;J Clin Oncol,2012

5. Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR;Maemondo;N Engl J Med,2010

Cited by 1145 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances and Ongoing Challenges in the Prevention and Control of Lung Cancer;International Encyclopedia of Public Health;2025

2. Simultaneous determination of icotinib, osimertinib, aumolertinib, and anlotinib in human plasma for therapeutic drug monitoring by UPLC-MS/MS;Journal of Pharmaceutical and Biomedical Analysis;2024-12

3. Taxus chinensis var. mairei (Lemée et Lévl) Cheng et L.K. Fu overcomes the resistance to osimertinib in EGFR-mutant non-small-cell lung cancer via suppression of ERK1/2-related cholesterol biosynthesis;Journal of Ethnopharmacology;2024-11

4. Combination of radiotherapy and PD-L1 blockade induces abscopal responses in EGFR-mutated lung cancer through activating CD8+ T cells;Translational Oncology;2024-10

5. Letter to the Editor — Addressing Complexities in Lung Adenocarcinoma Trends: PM2.5 Air Pollution, CT Screening, and Public Health Implications in Taiwan;Environmental Research;2024-09